NASDAQ:AGEN
Agenus Inc. Stock News
$10.50
-0.280 (-2.60%)
At Close: May 16, 2024
Bristol-Myers (BMY) Teams Up With Agenus for Antibody Program
11:16am, Wednesday, 19'th May 2021
Bristol-Myers (BMY) obtains exclusive license for Agenus' antibody program, AGEN1777, for an upfront payment of $200 million and up to $1.36 billion in milestone payments.
2 Grossly Undervalued Biotech Stocks That Could Double Your Money
10:00am, Wednesday, 19'th May 2021
Aurinia Pharmaceuticals and Agenus might be poised for a healthy growth spurt.
Agenus (AGEN) Soars on Global License Deal With Bristol-Myers
09:46am, Wednesday, 19'th May 2021
Agenus (AGEN) inks a definitive agreement with Bristol-Myers, wherein it will grant license to its bispecific antibody program AGEN1777 and another undisclosed target, to the latter.
Why Agenus Stock Skyrocketed Today
04:20pm, Tuesday, 18'th May 2021
The biotech announced a big licensing deal with Bristol Myers Squibb.
Biotech Penny Stocks Are On Fire Today, Here's 3 to Watch Under $5
11:44am, Tuesday, 18'th May 2021
Biotech penny stocks continue to heat up; here's 4 under $5 to look into The post Biotech Penny Stocks Are On Fire Today, Here's 3 to Watch Under $5 appeared first on Penny Stocks to Buy, Picks, News
Bristol Myers Inks $1.6B Licensing Agreement For Agenus' Bispecific Antibody Program In Solid Tumors
09:16am, Tuesday, 18'th May 2021
Bristol-Myers Squibb Co (NYSE: BMY) and Agenus Inc (NASDAQ: AGEN) have entered into a global exclusive license agreement, under which Bristol Myers will receive an exclusive license to Agenus' AGE
Agenus (AGEN) Stock: Over 30% Increase Pre-Market Explanation
09:14am, Tuesday, 18'th May 2021
The stock price of Agenus Inc (NASDAQ: AGEN) increased by over 30% pre-market. This is why it happened.
Conference Call on Tuesday, May 18, 2021 at 8:30 a.m. ET Conference Call on Tuesday, May 18, 2021 at 8:30 a.m. ET
Agenus and Bristol Myers Squibb Announce Exclusive Global License for Agenus' Anti-TIGIT Bispecific Antibody Program
07:30am, Tuesday, 18'th May 2021
Agenus to receive a $200 million upfront payment and up to $1.36 billion in milestone payments Agenus to receive a $200 million upfront payment and up to $1.36 billion in milestone payments
7 Small-Cap Biotech Stocks to Watch for Upcoming Catalysts
03:45pm, Wednesday, 12'th May 2021
Small-cap stocks in the biotech space have been in a slump, but these seven companies could see big moves just around the corner. The post 7 Small-Cap Biotech Stocks to Watch for Upcoming Catalysts ap
Why Agenus Stock Tumbled Today
03:55pm, Thursday, 06'th May 2021
The company announced mixed Q1 results on a day when many biotech stocks were sinking.
Agenus ' (AGEN) CEO Garo Armen on Q1 2021 Results - Earnings Call Transcript
12:02pm, Thursday, 06'th May 2021
Agenus ' (AGEN) CEO Garo Armen on Q1 2021 Results - Earnings Call Transcript
Agenus Corporate Update and First Quarter 2021 Financial Report
07:45am, Thursday, 06'th May 2021
LEXINGTON, Mass., May 06, 2021 (GLOBE NEWSWIRE) -- Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline of checkpoint antibodies, cell therapies, adjuvants, and vaccines d
Agenus to Present at the 2021 ASCO Annual Meeting
05:30pm, Wednesday, 28'th Apr 2021
LEXINGTON, Mass., April 28, 2021 (GLOBE NEWSWIRE) -- Agenus (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline of checkpoint antibodies, cell therapies, adjuvants, and vaccines desi
Agenus to Provide Corporate Update and First Quarter 2021 Financial Report
04:05pm, Thursday, 22'nd Apr 2021
Conference Call on Thursday, May 6, 2021 at 8:30 a.m. ET Conference Call on Thursday, May 6, 2021 at 8:30 a.m. ET